DK3378856T3 - Krystallinske methylthioniniumchlorid-hydrater - Google Patents

Krystallinske methylthioniniumchlorid-hydrater Download PDF

Info

Publication number
DK3378856T3
DK3378856T3 DK18170358.8T DK18170358T DK3378856T3 DK 3378856 T3 DK3378856 T3 DK 3378856T3 DK 18170358 T DK18170358 T DK 18170358T DK 3378856 T3 DK3378856 T3 DK 3378856T3
Authority
DK
Denmark
Prior art keywords
crystallinic
methylthioninium chloride
chloride hydrates
hydrates
methylthioninium
Prior art date
Application number
DK18170358.8T
Other languages
English (en)
Inventor
Rolf Hilfiker
Timo Rager
Original Assignee
Wista Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43415329&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3378856(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wista Lab Ltd filed Critical Wista Lab Ltd
Application granted granted Critical
Publication of DK3378856T3 publication Critical patent/DK3378856T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4515Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/22[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DK18170358.8T 2009-09-24 2010-09-23 Krystallinske methylthioniniumchlorid-hydrater DK3378856T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24539109P 2009-09-24 2009-09-24
EP15176967.6A EP2963024B1 (en) 2009-09-24 2010-09-23 Crystalline methylthioninium chloride hydrates - part 2

Publications (1)

Publication Number Publication Date
DK3378856T3 true DK3378856T3 (da) 2020-12-21

Family

ID=43415329

Family Applications (4)

Application Number Title Priority Date Filing Date
DK18170358.8T DK3378856T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioniniumchlorid-hydrater
DK15176967.6T DK2963024T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioniniumchloridhydrater - del 2
DK20203173.8T DK3792254T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioninium-chloridhydrater
DK10771516.1T DK2480541T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioniniumchlorid (methylenblåt)-hydrater

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK15176967.6T DK2963024T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioniniumchloridhydrater - del 2
DK20203173.8T DK3792254T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioninium-chloridhydrater
DK10771516.1T DK2480541T3 (da) 2009-09-24 2010-09-23 Krystallinske methylthioniniumchlorid (methylenblåt)-hydrater

Country Status (20)

Country Link
US (1) US8765742B2 (da)
EP (4) EP2963024B1 (da)
JP (1) JP5806217B2 (da)
KR (3) KR20180094126A (da)
CN (2) CN105061358A (da)
AU (1) AU2010299571B2 (da)
BR (4) BR122019022628B8 (da)
CA (4) CA3077911C (da)
DK (4) DK3378856T3 (da)
ES (4) ES2960761T3 (da)
FI (1) FI3792254T3 (da)
HK (2) HK1167653A1 (da)
HR (3) HRP20231201T1 (da)
MX (2) MX2012003083A (da)
MY (1) MY159782A (da)
PL (4) PL3378856T3 (da)
PT (4) PT3378856T (da)
SG (1) SG10201408584UA (da)
SI (4) SI2480541T1 (da)
WO (1) WO2011036558A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
AU2010299574B2 (en) * 2009-09-24 2013-09-26 Wista Laboratories Ltd. Process
CN109846862A (zh) 2012-10-25 2019-06-07 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
EP3060205A4 (en) 2013-10-22 2017-06-28 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
US10765755B1 (en) 2013-11-20 2020-09-08 University Of South Florida Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies
KR20240074909A (ko) 2016-07-25 2024-05-28 위스타 레보레이토리스 리미티드 디아미노페노티아진 (diaminophenothiazines)의 투여 및 투여량 (dosage)
AU2017321782B2 (en) 2016-08-31 2022-03-10 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
GB201614834D0 (en) 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
EP3654946A4 (en) 2017-07-20 2021-04-21 AZTherapies, Inc. POWDER FORMULATIONS OF CROMOLYN SODIUM AND IBUPROFEN
CA3105392A1 (en) 2018-07-02 2020-01-09 The General Hospital Corporation Powdered formulations of cromolyn sodium and .alpha.-lactose
WO2023232764A1 (en) 2022-05-31 2023-12-07 Wista Laboratories Ltd. Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds
WO2024063700A1 (en) 2022-09-21 2024-03-28 Yin Sze Loh Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0322756D0 (en) 2003-09-29 2003-10-29 Univ Aberdeen Methods of chemical synthesis
DK2322517T3 (da) 2004-09-23 2019-06-11 Wista Lab Ltd Fremgangsmåder til kemisk syntese og oprensning af diaminophenothiaziniumforbindelser med methylthioniniumchlorid (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
WO2007110627A2 (en) * 2006-03-29 2007-10-04 Wista Laboratories Ltd. 3,7-diamino-10h-phenothiazine salts and their use
AU2007231126B2 (en) * 2006-03-29 2012-11-01 Wista Laboratories Ltd. Inhibitors of protein aggregation
EP2137172A1 (en) * 2007-04-03 2009-12-30 Prosetta Bioconformatics Inc. Phenothiazin derivatives for antiviral treatments
US7603854B2 (en) 2007-04-10 2009-10-20 Illinois Tool Works Inc. Pneumatically self-regulating valve

Also Published As

Publication number Publication date
EP2480541B1 (en) 2015-11-04
WO2011036558A9 (en) 2011-08-04
CA3004822A1 (en) 2011-03-31
PL2963024T3 (pl) 2019-02-28
KR20180094126A (ko) 2018-08-22
SI3378856T1 (sl) 2021-03-31
WO2011036558A3 (en) 2011-11-24
MY159782A (en) 2017-01-31
US8765742B2 (en) 2014-07-01
HRP20181567T1 (hr) 2018-11-30
MX355627B (es) 2018-04-25
CA3004822C (en) 2020-07-21
BR112012006638B1 (pt) 2020-05-26
EP3378856A2 (en) 2018-09-26
SI3792254T1 (sl) 2023-11-30
EP3378856A3 (en) 2018-11-07
HK1167653A1 (en) 2012-12-07
PT2480541E (pt) 2016-01-26
SI2963024T1 (sl) 2018-10-30
PT2963024T (pt) 2018-10-16
CN102666511B (zh) 2015-09-16
PL3378856T3 (pl) 2021-05-31
EP2963024A2 (en) 2016-01-06
PL2480541T3 (pl) 2016-03-31
BR112012006638A2 (pt) 2016-05-03
JP2013505925A (ja) 2013-02-21
BR122019022612B8 (pt) 2021-07-27
MX2012003083A (es) 2012-04-30
CA3141737A1 (en) 2011-03-31
AU2010299571B2 (en) 2014-07-31
CA2773305C (en) 2018-07-03
HRP20231201T1 (hr) 2024-01-19
US20120238556A1 (en) 2012-09-20
KR20120099409A (ko) 2012-09-10
CA2773305A1 (en) 2011-03-31
ES2960761T3 (es) 2024-03-06
DK3792254T3 (da) 2023-09-25
EP2963024A3 (en) 2016-02-17
FI3792254T3 (fi) 2023-09-22
CA3077911C (en) 2022-03-01
BR122019022631B1 (pt) 2021-03-16
BR122019022631B8 (pt) 2021-07-27
AU2010299571A1 (en) 2012-04-12
DK2963024T3 (da) 2018-10-08
EP3378856B1 (en) 2020-12-02
KR20170061177A (ko) 2017-06-02
BR122019022612B1 (pt) 2021-03-09
JP5806217B2 (ja) 2015-11-10
PT3378856T (pt) 2021-02-02
BR122019022628B1 (pt) 2021-03-16
EP2480541A2 (en) 2012-08-01
EP3792254B1 (en) 2023-07-26
PT3792254T (pt) 2023-10-19
EP3792254A1 (en) 2021-03-17
CA3077911A1 (en) 2011-03-31
ES2557318T3 (es) 2016-01-25
PL3792254T3 (pl) 2024-02-12
ES2689029T3 (es) 2018-11-08
CN105061358A (zh) 2015-11-18
CA3141737C (en) 2023-10-03
SG10201408584UA (en) 2015-02-27
HK1213897A1 (zh) 2016-07-15
CN102666511A (zh) 2012-09-12
HRP20181567T2 (hr) 2022-09-30
EP2963024B1 (en) 2018-07-18
HRP20210086T1 (hr) 2021-03-05
WO2011036558A2 (en) 2011-03-31
BR122019022628B8 (pt) 2021-07-27
DK2480541T3 (da) 2016-02-01
SI2480541T1 (sl) 2016-02-29
ES2847003T3 (es) 2021-07-30

Similar Documents

Publication Publication Date Title
NL301265I1 (nl) Quizartinib
DK3378856T3 (da) Krystallinske methylthioniniumchlorid-hydrater
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
DK2411442T4 (da) Umættet polyesterresin
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
BR112012000657A2 (pt) novos azabicilohexanos
UY33156A (es) Nuevos compuestos tienopirrol
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
DK2483126T3 (da) Skinnekøretøj
DK2506968T3 (da) Faujasit-zeolit
DE112010004865T8 (de) Lamellennassreibkupplung
DE102010012963A8 (de) Bohrwerkzeug
DK2213923T3 (da) Drejeled
BR112013000371A2 (pt) invólucro
DE112010003255A5 (de) Fördergutverteiler
BRPI1010159A2 (pt) bistuti
DE602010000025D1 (de) Fahrzeugsitzgurtvorrichtung
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas